CENCORP CORPORATION COMMITS ITS MANAGEMENT –COMPANY HAS

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CENCORP CORPORATION COMMITS ITS MANAGEMENT –COMPANY HAS RESOLVED ON THE DIRECTED SHARE ISSUE FOR THE FEE FOR CERTAIN DIRECTORS AND EMPLOYEES AND FORMED MEMBER OF THE BOARD OF DIRECTORS OF THE COMPANY

CENCORP CORPORATION STOCK EXCHANGE RELEASE      April 11, 2014 at 12:30 Finnish time

CENCORP CORPORATION COMMITS ITS MANAGEMENT –COMPANY HAS RESOLVED ON THE DIRECTED SHARE ISSUE FOR THE FEE FOR CERTAIN DIRECTORS AND EMPLOYEES AND FORMED MEMBER OF THE BOARD OF DIRECTORS OF THE COMPANY

The Board of Directors of Cencorp Corporation (the ”Company”) has today resolved pursuant to the authorization granted to it by the extraordinary general meeting of the Company held on January 30, 2012 to issue directly in total maximum of 10.653.120 new Company shares for a fee to the members of the Company's Management Team, except for the President and CEO Iikka Savisalo, and to the Company employees Marc Van Dongen and Jose Basso  and for a former member of the Board of Directors Ismo Rautiainen. The President and CEO Iikka Savisalo owns through companies Savcor Group Oy and SCI Invest Oy 353.461.787 shares of Cencorp and this being is committed already through his ownerships to the Company.

The subscription price for the shares in the share issue is 0,025 euro per share and the total amount of the directed share issue is thus 266.328 euro.

The directed share issue is executed by deviating from the shareholders' pre-emptive subscription right. The ground for the directed share issue with respect to the members of the Management Team and employees of the Company is committing persons to the Company and for the former member of the Board of Directors the non-disputed receivables from the Company which he has consisting of matured remuneration fees relating to the board membership between the years 2011 and 2013. Consequently, the Company has a weighty financial reason for deviating from the shareholders’ pre-emptive subscription right.

The subscription period is from April 11, 2014 to April 24, 2014. The payment of the share subscriptions shall take place to the Company's bank account referred to in the subscription lists or by setting-off the non-disputed receivables corresponding the subscription amounts which the subscribers have from the Company by the end of the subscription period.

In the event all offered shares are subscribed and approved the amount of the shares in the Company shall increase from 854.312.315 shares to 864.965.435 shares once the new shares have been registered with the Trade Register.

The Company aims to apply for listing of the new shares at the official list of NASDAQ OMX Helsinki Ltd together with the shares already issued and listed. For the listing of the new shares, the Company will separately publish a supplement to the Registration Document dated December 9, 2013 as well as a Summary and a Securities Note prior to the listing of the new shares.

The terms and conditions for the directed share issue are as a whole attached as appendix 1 to this stock exchange release.

In Mikkeli, April 11, 2014

CENCORP CORPORATION

For more information: 

Iikka Savisalo

President and CEO

Cencorp Oyj 

Tel. +358 40 521 6082,

Email: iikka.sav isalo@cencorp.com 

Distribution:

NASDAQ OMX, Helsinki

Main media

www.cencorp.com

Cencorp Corporation is a leading provider of industrial automation solutions. The equipment in the product portfolio include, automated applications of odd-form assembly and  depaneling for the electronic boards, testing equipment and advanced materials processing by laser. All Cencorp's offering improves the efficiency of the customers' production. Cencorp has clean technology, especially photovoltaic (PV) solutions as its other business segment. Cencorp now offers its automated manufacturing technology of the PV modules, manufactures and sells photovoltaic modules, based on Cencorp´s own technology as well as key components of photovoltaic modules. The product range also includes EMI shielding solutions, RFID antennas, other flexible circuits including for example conductive back sheets used in photovoltaic modules and mobile phone antennas. Cencorp's head office is located in Mikkeli, Finland. The company is part of the Finnish Savcor Group.

APPENDIX 1 Terms and conditions of the Directed Share Issue

TERMS AND CONDITINS OF THE DIRECTED SHARE ISSUE 1/2014

The Board of Directors of Cencorp Corporation (hereinafter the ”Company”) resolves to offer for subscription of members of the Company's Management Team (except for the President and CEO) Company employees Marc Van Dongen and Jose Basso  and a former member of the Board of Directors in total 10.653.120 new shares of the Company for a fee pursuant to the authorization granted to the Board of Directors by the Extraordinary General Meeting of the Company held on 30 January 2012 in accordance with the following terms and conditions:

1.By deviating from the pre-emptive subscription right of the shareholders the following parties are offered to subscribe in maximum new shares of the Company as follows:

-Jari Ketoluoto 580.000 new shares,

-Petri Kivelä 580.000 new shares,

-Seija Kurki 580.000 new shares,

-Sami Lindfors 580.000 new shares,

-Jose Basso 580.000 new shares,

-Henrikki Pantsar 1.184.200 new shares,

-Ismo Rautiainen 2.149.840 new shares and

-Marc Van Dongen 4.419.080 new shares

In total 10.653.120 new shares of the Company

2. The total amount of the directed share issue is in maximum 266.328 euro.

3.The share issue is implemented by deviating from the pre-emptive subscription right of the shareholders. The ground for the directed share issue with respect to the members of the Management Team and employees of the Company is committing persons to the Company and for the former member of the Board of Directors the non-disputed receivables from the Company which he has consisting of matured remuneration fees relating to the board membership between the years 2011 and 2013. Consequently, the Company has a weighty financial reason for deviating from the shareholders’ pre-emptive subscription rights.

4.The subscription price shall be 0,025 euro per share. The subscription price is based on the stock price of Company’s share and recent development of volume-weighted middle price of Company’s shares. The subscription price shall be recorded entirely to the Company’s invested free equity fund.

5.The subscription right is not transferable. In the event not all the offered shares are subscribed other shareholders or third parties have no secondary subscription right.

6.The shares shall be subscribed within the subscription period of April 11, 2014 and April 24, 2014 in the subscription lists to be provided separately for all the persons being entitled for subscriptions which shall be returned to the Company latest on April 24, 2014. The Board of Directors is entitled to resolve on the extension to the subscription period.

7.The payment of the share subscriptions shall take place to the Company's bank account referred to in the subscription lists or by setting-off the non-disputed receivables which the subscribers have from the Company by the end of the subscription period. The Board of Directors is entitled to resolve on the extension to the payment period for subscriptions.

8.The Board of Directors shall resolve on the acceptance of the share subscriptions.

9. The Board of Directors shall take care of the entries of the shares to the Trade Register without undue delay after the decision of the Board of Directors on the acceptance of the share subscriptions has taken place.

10.After the shares offered in the share issue have been entered in the Trade Register, they will confer the same rights as other shares in the Company and they will entitle to all dividends that will be paid in the future. Each share entitles to one vote in the General Meeting.

11.The number of Company's shares immediately prior to the directed share issue is 854,312,315. The number of Company's shares immediately after execution of the directed share issue is 864,965,435 provided that all the offered Company's new shares are subscribed within the share issue. The share capital shall not be increased in connection with the share issue.

12.The Board of Directors shall resolve on all other issues related to the directed share issue.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 31

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 655

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 83

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

VivoPower Innovates with XRP-Focused Treasury Strategy

Updated Category News Views 359

VivoPower's Transformational XRP Strategy VivoPower International PLC (NASDAQ: VVPR) has recently embarked on a groundbreaking journey by announcing a new strategy centered on the digital asset XRP. The company is positioning itself as the first publicly traded entity to implement an XRP-focused digital asset treasury. This innovative approach is not only exciting for...

Continue Reading
Recognizing Excellence in Product Stewardship for 2024

Updated Category News Views 114

Celebrating Product Stewardship Excellence The Product Stewardship Society has announced a significant honor for 2024—Lynn L. Bergeson has been named the recipient of the prestigious Allan K. Fleeger Distinguished Service Award. This esteemed award has been established to acknowledge the remarkable contributions of individual product stewards who have played crucial...

Continue Reading
Gold Hits New Heights Amid Tensions and Election Uncertainty

Updated Category News Views 163

Gold Prices Surge to Record Heights In recent trading, gold prices have reached unprecedented levels, reflecting a significant rise driven by various factors, including political uncertainties and ongoing international conflicts. As anticipation surrounding a highly competitive U.S. presidential election grows, along with persistent tensions in regions such as the Middle...

Continue Reading
Paul Jebely Joins Sterlington as Aviation Law Vice Chair

Updated Category News Views 257

Paul Jebely Joins Sterlington as New Partner Sterlington PLLC is excited to announce that Paul Jebely has joined the firm as their new Partner and Vice Chair of International, marking a crucial advancement in their aviation law practice. Jebely is not just any attorney; he is a globally recognized authority in private aviation law, especially known for his work with...

Continue Reading
William James Wartinbee III Executes Significant Sell Strategy

Updated Category News Views 62

William James Wartinbee III Implements Key Sell Strategy In a noteworthy insider sale, William James Wartinbee III, the Executive Vice President at Gartner (IT), has sold 210 shares of the company. This transaction was documented in a Form 4 filing with the U.S. Securities and Exchange Commission, and the sale was valued at about $103,275. Examining Gartner's Current...

Continue Reading